{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:23:57Z","timestamp":1786994637018,"version":"build-2736575974"},"reference-count":231,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"American Academy of Neurology"},{"name":"Oakstone Publishing, Inc"},{"DOI":"10.13039\/100000049","name":"NIA","doi-asserted-by":"publisher","award":["R01 AG AG031189"],"award-info":[{"award-number":["R01 AG AG031189"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alliance Biosecure"},{"name":"the Michael J. Homer Family Fund"},{"DOI":"10.13039\/100008539","name":"CurePSP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008539","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tau Consortium"},{"name":"Quest Diagnostics"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ncl.2018.07.005","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T19:33:18Z","timestamp":1540323198000},"page":"865-897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Prion Diseases"],"prefix":"10.1016","volume":"36","author":[{"given":"Boon Lead","family":"Tee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika Mariana","family":"Longoria Ibarrola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Geschwind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.ncl.2018.07.005_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00002093-198903010-00002","article-title":"On a particular focal disease of the central nervous system (preliminary communication), 1920","volume":"3","author":"Creutzfeldt","year":"1989","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1016\/j.ncl.2018.07.005_bib2","first-page":"372","article-title":"Concerning a disorder of the central nervous system clinically resembling multiple sclerosis with remarkable anatomic findings (spastic pseudosclerosis). Report of a fourth case","volume":"17","author":"Jakob","year":"1921","journal-title":"Med Klin"},{"key":"10.1016\/j.ncl.2018.07.005_bib3","series-title":"Prion diseases of humans and animals","first-page":"53","article-title":"Spongiform encephalopathies - slow, latent, and temperate virus infections - in retrospect","author":"Gibbs","year":"1992"},{"key":"10.1016\/j.ncl.2018.07.005_bib4","series-title":"Neurological classics in modern translation","first-page":"95","article-title":"Introduction to myoclonic dementia","author":"Richardson","year":"1977"},{"key":"10.1016\/j.ncl.2018.07.005_bib5","series-title":"Recent advances in neuropathology. Number 2","first-page":"139","article-title":"The spectrum of Creutzfeldt-Jakob disease and the\u00a0virus-induced subacute spongiform encephalopathies","author":"Masters","year":"1982"},{"issue":"6680","key":"10.1016\/j.ncl.2018.07.005_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/29862","article-title":"It's Jakob's disease, not Creutzfeldt's","volume":"393","author":"Katscher","year":"1998","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.ncl.2018.07.005_bib7","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(12)70063-7","article-title":"Sporadic human prion diseases: molecular insights and diagnosis","volume":"11","author":"Puoti","year":"2012","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ana.410050212","article-title":"Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering","volume":"5","author":"Masters","year":"1979","journal-title":"Ann Neurol"},{"issue":"6\u00a0Neuroinfectious Disease","key":"10.1016\/j.ncl.2018.07.005_bib9","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1212\/CON.0000000000000251","article-title":"Prion diseases","volume":"21","author":"Geschwind","year":"2015","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.ncl.2018.07.005_bib10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/B978-0-444-64076-5.00029-6","article-title":"Prion disease","volume":"148","author":"Takada","year":"2018","journal-title":"Handb Clin Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/ana.10267","article-title":"Spontaneous mutations in the prion protein gene causing transmissible spongiform encephalopathy","volume":"52","author":"Dagvadorj","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2018.07.005_bib12","first-page":"441","article-title":"Prion disease","volume":"vol. 148","author":"Takada","year":"2018"},{"issue":"9","key":"10.1016\/j.ncl.2018.07.005_bib13","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1212\/01.WNL.0000160117.56690.B2","article-title":"Mortality from Creutzfeldt-Jakob disease and related disorders in Europe, Australia, and Canada","volume":"64","author":"Ladogana","year":"2005","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib14","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/oxfordjournals.bmb.a072655","article-title":"Epidemiology of Creutzfeldt-Jakob disease","volume":"49","author":"Will","year":"1993","journal-title":"Br Med Bull"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib15","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a024364","article-title":"Sporadic and infectious human prion diseases","volume":"7","author":"Will","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"Pt 9","key":"10.1016\/j.ncl.2018.07.005_bib16","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/brain\/awl159","article-title":"Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease","volume":"129","author":"Collins","year":"2006","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W","article-title":"Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects","volume":"46","author":"Parchi","year":"1999","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2018.07.005_bib18","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3201\/eid1806.120116","article-title":"Iatrogenic Creutzfeldt-Jakob disease, final assessment","volume":"18","author":"Brown","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.ncl.2018.07.005_bib19","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a033134","article-title":"Genetic PrP prion diseases","volume":"10","author":"Kim","year":"2018","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00439-005-0020-1","article-title":"Genetic prion disease: the EUROCJD experience","volume":"118","author":"Kovacs","year":"2005","journal-title":"Hum Genet"},{"issue":"12","key":"10.1016\/j.ncl.2018.07.005_bib21","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1001\/jamaneurol.2016.3733","article-title":"Diagnosing sporadic Creutzfeldt-Jakob disease by the detection of abnormal prion protein in patient urine","volume":"73","author":"Luk","year":"2016","journal-title":"JAMA Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2018.07.005_bib22","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.410200507","article-title":"Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases","volume":"20","author":"Brown","year":"1986","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2018.07.005_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/ana.410350504","article-title":"Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease","volume":"35","author":"Brown","year":"1994","journal-title":"Ann Neurol"},{"issue":"2 Dementia","key":"10.1016\/j.ncl.2018.07.005_bib24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1212\/01.CON.0000368211.79211.4c","article-title":"Rapidly progressive dementia: prion diseases and other rapid dementias","volume":"16","author":"Geschwind","year":"2010","journal-title":"Continuum (Minneap Minn)"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/jnnp.47.2.134","article-title":"A\u00a0retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I: clinical features","volume":"47","author":"Will","year":"1984","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1212\/01.wnl.0000196440.00297.67","article-title":"First symptom in sporadic Creutzfeldt-Jakob disease","volume":"66","author":"Rabinovici","year":"2006","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib27","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ncl.2007.04.001","article-title":"Rapidly progressive dementia","volume":"25","author":"Geschwind","year":"2007","journal-title":"Neurol Clin"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1001\/2013.jamaneurol.139","article-title":"Sporadic Jakob-Creutzfeldt disease presenting as primary progressive aphasia","volume":"70","author":"Johnson","year":"2013","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2018.07.005_bib29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/ana.410390613","article-title":"Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease","volume":"39","author":"Parchi","year":"1996","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.24833","article-title":"Diagnostic and prognostic value of human prion detection in cerebrospinal fluid","volume":"81","author":"Foutz","year":"2017","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2018.07.005_bib31","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/ana.20261","article-title":"Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease","volume":"56","author":"Steinhoff","year":"2004","journal-title":"Ann Neurol"},{"issue":"13","key":"10.1016\/j.ncl.2018.07.005_bib32","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199609263351303","article-title":"The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies","volume":"335","author":"Hsich","year":"1996","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.410430109","article-title":"Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease","volume":"43","author":"Zerr","year":"1998","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2018.07.005_bib34","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/archneur.60.6.813","article-title":"Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease","volume":"60","author":"Geschwind","year":"2003","journal-title":"Arch Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2018.07.005_bib35","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/jnnp.2009.197962","article-title":"The role of cerebrospinal fluid 14-3-3 and other proteins in the diagnosis of sporadic Creutzfeldt-Jakob disease in the UK: a 10-year review","volume":"81","author":"Chohan","year":"2010","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"14","key":"10.1016\/j.ncl.2018.07.005_bib36","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1212\/WNL.0b013e31826d5fc3","article-title":"Evidence-based guideline: diagnostic accuracy of CSF 14-3-3 protein in sporadic Creutzfeldt-Jakob disease: report of the guideline development subcommittee of the American Academy of Neurology","volume":"79","author":"Muayqil","year":"2012","journal-title":"Neurology"},{"issue":"Pt 10","key":"10.1016\/j.ncl.2018.07.005_bib37","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1093\/brain\/aws238","article-title":"Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years","volume":"135","author":"Stoeck","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2018.07.005_bib38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/1471-2377-11-133","article-title":"Diagnostic accuracy of cerebrospinal fluid protein markers for sporadic Creutzfeldt-Jakob disease in Canada: a 6-year prospective study","volume":"11","author":"Coulthart","year":"2011","journal-title":"BMC Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib39","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2009.02.067","article-title":"The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease","volume":"455","author":"Pennington","year":"2009","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib40","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00401-017-1683-0","article-title":"Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Abeta42 levels","volume":"133","author":"Lattanzio","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib41","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1212\/01.WNL.0000078890.89473.ED","article-title":"14-3-3 protein in the CSF of patients with rapidly progressive dementia","volume":"61","author":"Huang","year":"2003","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ncl.2018.07.005_bib42","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1212\/WNL.55.9.1396","article-title":"Misleading results with the 14-3-3 assay for the diagnosis of Creutzfeldt-Jakob disease","volume":"55","author":"Chapman","year":"2000","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ncl.2018.07.005_bib43","first-page":"1278","article-title":"CSF 14-3-3 protein assay and MRI as prognostic markers in patients with a clinically isolated syndrome suggestive of MS","volume":"251","author":"Martinez-Yelamos","year":"2004","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.ncl.2018.07.005_bib44","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1212\/WNL.57.4.722","article-title":"14-3-3 protein in the CSF as prognostic marker in early multiple sclerosis","volume":"57","author":"Martinez-Yelamos","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib45","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1440-1789.2005.00595.x","article-title":"Miliary brain metastases presenting as rapidly progressive dementia","volume":"25","author":"Rivas","year":"2005","journal-title":"Neuropathology"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2018.07.005_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-510X(03)00083-2","article-title":"Detection of the 14-3-3 protein in the cerebrospinal fluid of Japanese multiple sclerosis patients presenting with severe myelitis","volume":"212","author":"Satoh","year":"2003","journal-title":"J\u00a0Neurol Sci"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib47","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3233\/JAD-2012-120007","article-title":"Rapidly progressive Alzheimer's disease: a multicenter update","volume":"30","author":"Schmidt","year":"2012","journal-title":"J\u00a0Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib48","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ageing\/afn094","article-title":"Basic D. Rapidly progressive Alzheimer's disease and elevated 14-3-3 proteins in cerebrospinal fluid","volume":"37","author":"Jayaratnam","year":"2008","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib49","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1515\/CCLM.2011.086","article-title":"Tau and p-tau as CSF biomarkers in dementia: a meta-analysis","volume":"49","author":"van Harten","year":"2011","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib50","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000008054","article-title":"The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture","volume":"41","author":"Satoh","year":"1999","journal-title":"Eur Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib51","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1212\/CPJ.0000000000000111","article-title":"Comparing CSF biomarkers and brain MRI in the diagnosis of sporadic Creutzfeldt-Jakob disease","volume":"5","author":"Forner","year":"2015","journal-title":"Neurol Clin Pract"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib52","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/WCO.0000000000000197","article-title":"Clinical update of Jakob-Creutzfeldt disease","volume":"28","author":"Kim","year":"2015","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2018.07.005_bib53","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1212\/WNL.0b013e318263565f","article-title":"A\u00a0comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease","volume":"79","author":"Hamlin","year":"2012","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib54","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000017095","article-title":"14-3-3 protein, neuron-specific enolase, and S-100 protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease","volume":"10","author":"Beaudry","year":"1999","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"5","key":"10.1016\/j.ncl.2018.07.005_bib55","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3109\/13550289809113503","article-title":"Elevated levels of serum S100 beta protein in scrapie hamsters","volume":"4","author":"Otto","year":"1998","journal-title":"J\u00a0Neurovirol"},{"issue":"5","key":"10.1016\/j.ncl.2018.07.005_bib56","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/jnnp-2017-316853","article-title":"Imaging and CSF analyses effectively distinguish CJD from its mimics","volume":"89","author":"Rudge","year":"2018","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib57","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1001\/jamaneurol.2013.6455","article-title":"Diagnostic performance of cerebrospinal fluid total tau and phosphorylated tau in Creutzfeldt-Jakob disease: results from the Swedish Mortality Registry","volume":"71","author":"Skillback","year":"2014","journal-title":"JAMA Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2018.07.005_bib58","first-page":"1147","article-title":"Diagnostic value of 14-3-3beta immunoblot and T-tau\/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease","volume":"16","author":"Blennow","year":"2005","journal-title":"Int J Mol Med"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib59","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/sj.mp.4001220","article-title":"Phospho-tau\/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias","volume":"8","author":"Riemenschneider","year":"2003","journal-title":"Mol Psychiatry"},{"issue":"2 Dementia","key":"10.1016\/j.ncl.2018.07.005_bib60","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1212\/CON.0000000000000319","article-title":"Rapidly progressive dementia","volume":"22","author":"Geschwind","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib61","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nm.2294","article-title":"Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion","volume":"17","author":"Atarashi","year":"2011","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib62","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ana.23589","article-title":"Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease","volume":"72","author":"McGuire","year":"2012","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib63","doi-asserted-by":"crossref","first-page":"10655","DOI":"10.1038\/s41598-017-10922-w","article-title":"High diagnostic value of second generation CSF RT-QuIC across the wide spectrum of CJD prions","volume":"7","author":"Franceschini","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib64","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/ana.24679","article-title":"Cerebrospinal fluid real-time quaking-induced conversion is a robust and reliable test for sporadic Creutzfeldt-Jakob disease: an international study","volume":"80","author":"McGuire","year":"2016","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib65","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jamaneurol.2016.4614","article-title":"Diagnosis of human prion disease using real-time quaking-induced conversion testing of olfactory mucosa and cerebrospinal fluid samples","volume":"74","author":"Bongianni","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2018.07.005_bib66","doi-asserted-by":"crossref","unstructured":"Satoh K, Takatsuki H, Atarashi R, et\u00a0al. CSF analysis of patients with human prion disease in a prospective study. Presented at Prion 2016. Tokyo, Japan. May 10\u201313, 2016.","DOI":"10.1080\/19336896.2016.1217733"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib67","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/jon199773171","article-title":"A\u00a066-year-old woman with a rapidly progressing dementia and basal ganglia involvement","volume":"7","author":"Gold","year":"1997","journal-title":"J\u00a0Neuroimaging"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib68","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s002340050542","article-title":"MRI in sporadic Creutzfeldt-Jakob disease: correlation with clinical and neuropathological data","volume":"40","author":"Urbach","year":"1998","journal-title":"Neuroradiology"},{"issue":"5","key":"10.1016\/j.ncl.2018.07.005_bib69","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1001\/archneur.56.5.577","article-title":"Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease","volume":"56","author":"Bahn","year":"1999","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib70","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1212\/WNL.52.1.205","article-title":"Diffusion-weighted MRI in sporadic Creutzfeldt-Jakob disease","volume":"52","author":"Demaerel","year":"1999","journal-title":"Neurology"},{"issue":"17","key":"10.1016\/j.ncl.2018.07.005_bib71","doi-asserted-by":"crossref","first-page":"L5","DOI":"10.1097\/00001756-200011270-00001","article-title":"Creutzfeldt-Jakob disease: analysis of the MRI signal","volume":"11","author":"Urbach","year":"2000","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib72","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/00004728-200103000-00022","article-title":"Creutzfeldt-Jakob disease: serial changes on diffusion-weighted MRI","volume":"25","author":"Matoba","year":"2001","journal-title":"J\u00a0Comput Assist Tomogr"},{"key":"10.1016\/j.ncl.2018.07.005_bib73","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1212\/01.WNL.0000134555.59460.5D","article-title":"Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt-Jakob disease","volume":"I63","author":"Shiga","year":"2004","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2018.07.005_bib74","first-page":"1551","article-title":"Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis","volume":"26","author":"Young","year":"2005","journal-title":"AJNR Am J Neuroradiol"},{"issue":"20","key":"10.1016\/j.ncl.2018.07.005_bib75","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/WNL.0b013e31821a4439","article-title":"Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias","volume":"76","author":"Vitali","year":"2011","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib76","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2377-12-153","article-title":"MRI findings are often missed in the diagnosis of Creutzfeldt-Jakob disease","volume":"12","author":"Carswell","year":"2012","journal-title":"BMC Neurol"},{"issue":"Supplement 2","key":"10.1016\/j.ncl.2018.07.005_bib77","first-page":"A213","article-title":"Brain MRI in sporadic Jakob-Creutzfeldt disease is often misread","volume":"74","author":"Geschwind","year":"2010","journal-title":"Neurology"},{"issue":"23","key":"10.1016\/j.ncl.2018.07.005_bib78","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1212\/WNL.0b013e3181a96e5d","article-title":"MRI lesion profiles in sporadic Creutzfeldt-Jakob disease","volume":"72","author":"Meissner","year":"2009","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ncl.2018.07.005_bib79","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jocn.2010.03.032","article-title":"MRI sequence findings in sporadic Creutzfeldt-Jakob disease","volume":"17","author":"Tian","year":"2010","journal-title":"J\u00a0Clin Neurosci"},{"issue":"5","key":"10.1016\/j.ncl.2018.07.005_bib80","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1055\/s-0037-1608808","article-title":"Neuroimaging in dementia","volume":"37","author":"Staffaroni","year":"2017","journal-title":"Semin Neurol"},{"key":"10.1016\/j.ncl.2018.07.005_bib81","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.nicl.2014.01.011","article-title":"Application of quantitative DTI metrics in sporadic CJD","volume":"4","author":"Caverzasi","year":"2014","journal-title":"Neuroimage Clin"},{"issue":"9","key":"10.1016\/j.ncl.2018.07.005_bib82","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archneur.1996.00550090125018","article-title":"Diagnostic criteria for sporadic Creutzfeldt-Jakob disease","volume":"53","author":"Kretzschmar","year":"1996","journal-title":"Arch Neurol"},{"issue":"19","key":"10.1016\/j.ncl.2018.07.005_bib83","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1212\/01.wnl.0000290370.14036.69","article-title":"A\u00a054-year-old man with slowness of movement and confusion","volume":"69","author":"Geschwind","year":"2007","journal-title":"Neurology"},{"issue":"Pt 10","key":"10.1016\/j.ncl.2018.07.005_bib84","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1093\/brain\/awp191","article-title":"Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease","volume":"132","author":"Zerr","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2018.07.005_bib85","series-title":"Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation Geneva, Switzerland 9-11 February 1998","author":"World Health Organization (WHO)","year":"1998"},{"key":"10.1016\/j.ncl.2018.07.005_bib86","unstructured":"UK National CJD Research & Surveillance Unit (NCJDRSU). Diagnostic criteria. 2017. Available at: https:\/\/www.cjd.ed.ac.uk\/surveillance. Accessed July 2, 2018."},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib87","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/ajmg.b.32505","article-title":"Genetic prion disease: experience of a rapidly progressive dementia center in the United States and a review of the literature","volume":"174","author":"Takada","year":"2017","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"issue":"322","key":"10.1016\/j.ncl.2018.07.005_bib88","doi-asserted-by":"crossref","first-page":"322ra329","DOI":"10.1126\/scitranslmed.aad5169","article-title":"Quantifying prion disease penetrance using large population control cohorts","volume":"8","author":"Minikel","year":"2016","journal-title":"Sci Transl Med"},{"issue":"8974","key":"10.1016\/j.ncl.2018.07.005_bib89","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(95)91405-6","article-title":"Transmission of fatal familial insomnia to laboratory animals","volume":"346","author":"Collinge","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib90","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1750-3639.1995.tb00577.x","article-title":"Inherited prion diseases and transmission to rodents","volume":"5","author":"Tateishi","year":"1995","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ncl.2018.07.005_bib91","unstructured":"American Red Cross. Eligibility reference material. Eligibility requirements for blood\u00a0donation. Creutzfeldt-Jakob disease. 2018. Available at: https:\/\/www.redcrossblood.org\/donate-blood\/how-to-donate\/eligibility-requirements\/eligibility-criteria-alphabetical\/eligibility-reference-material.html. Accessed May 1, 2018."},{"issue":"9528","key":"10.1016\/j.ncl.2018.07.005_bib92","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/S0140-6736(06)68930-7","article-title":"Kuru in the 21st century--an acquired human prion disease with very long incubation periods","volume":"367","author":"Collinge","year":"2006","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.ncl.2018.07.005_bib93","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1056\/NEJMoa0809716","article-title":"A\u00a0novel protective prion protein variant that colocalizes with kuru exposure","volume":"361","author":"Mead","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.ncl.2018.07.005_bib94","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/jnnp.2004.048660","article-title":"Molecular neurology of prion disease","volume":"76","author":"Collinge","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"8983","key":"10.1016\/j.ncl.2018.07.005_bib95","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(95)91827-2","article-title":"Sporadic Creutzfeldt-Jakob disease in a 16-year-old in the UK","volume":"346","author":"Britton","year":"1995","journal-title":"Lancet"},{"issue":"8983","key":"10.1016\/j.ncl.2018.07.005_bib96","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(95)91828-0","article-title":"Sporadic Creutzfeldt-Jakob disease in a 18-year-old in the UK","volume":"346","author":"Bateman","year":"1995","journal-title":"Lancet"},{"issue":"9006","key":"10.1016\/j.ncl.2018.07.005_bib97","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(96)91412-9","article-title":"A\u00a0new variant of Creutzfeldt-Jakob disease in the UK","volume":"347","author":"Will","year":"1996","journal-title":"Lancet"},{"issue":"7352","key":"10.1016\/j.ncl.2018.07.005_bib98","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1136\/bmj.324.7352.1479","article-title":"First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features","volume":"324","author":"Spencer","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ncl.2018.07.005_bib99","unstructured":"UK National CJD Research & Surveillance Unit. Creutzfeldt-Jakob disease surveillance in the UK. 25th Annual Report 2016. Available at: https:\/\/www.cjd.ed.ac.uk\/sites\/default\/files\/report25.pdf. Accessed June 27, 2018."},{"key":"10.1016\/j.ncl.2018.07.005_bib100","unstructured":"UK National CJD Research & Surveillance Unit. Variant Creutzfeldt-Jakob disease worldwide current data (February 2018). 2018. Available at: https:\/\/www.cjd.ed.ac.uk\/sites\/default\/files\/worldfigs.pdf. Accessed June 1, 2018."},{"issue":"5","key":"10.1016\/j.ncl.2018.07.005_bib101","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3201\/eid2105.142017","article-title":"Recent US case of variant Creutzfeldt-Jakob disease-global implications","volume":"21","author":"Maheshwari","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"Pt 10","key":"10.1016\/j.ncl.2018.07.005_bib102","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1093\/brain\/aww206","article-title":"A\u00a0case cluster of variant Creutzfeldt-Jakob disease linked to the Kingdom of Saudi Arabia","volume":"139","author":"Coulthart","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2018.07.005_bib103","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.neuro.24.1.519","article-title":"Prion diseases of humans and animals: their causes and molecular basis","volume":"24","author":"Collinge","year":"2001","journal-title":"Annu Rev Neurosci"},{"issue":"26","key":"10.1016\/j.ncl.2018.07.005_bib104","doi-asserted-by":"crossref","first-page":"15137","DOI":"10.1073\/pnas.96.26.15137","article-title":"Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans","volume":"96","author":"Scott","year":"1999","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib105","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3201\/eid0403.980311","article-title":"The emergence of bovine spongiform encephalopathy and related diseases","volume":"4","author":"Pattison","year":"1998","journal-title":"Emerg Infect Dis"},{"issue":"6650","key":"10.1016\/j.ncl.2018.07.005_bib106","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/39057","article-title":"Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent","volume":"389","author":"Bruce","year":"1997","journal-title":"Nature"},{"issue":"6650","key":"10.1016\/j.ncl.2018.07.005_bib107","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/38925","article-title":"The same prion strain causes vCJD and BSE","volume":"389","author":"Hill","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib108","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1136\/jnnp.45.3.235","article-title":"Evidence for case-to-case transmission of Creutzfeldt-Jakob disease","volume":"45","author":"Will","year":"1982","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"9213","key":"10.1016\/j.ncl.2018.07.005_bib109","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0140-6736(00)02140-1","article-title":"The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease","volume":"355","author":"Zeidler","year":"2000","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ncl.2018.07.005_bib110","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1212\/01.WNL.0000123265.91365.AF","article-title":"False-positive pulvinar sign on MRI in sporadic Creutzfeldt-Jakob disease","volume":"62","author":"Petzold","year":"2004","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib111","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1017\/S1092852900000043","article-title":"Pulvinar sign in Wernicke's encephalopathy","volume":"15","author":"Schmidt","year":"2010","journal-title":"CNS Spectr"},{"issue":"11","key":"10.1016\/j.ncl.2018.07.005_bib112","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.jocn.2007.05.022","article-title":"Wernicke's encephalopathy mimicking variant Creutzfeldt-Jakob disease","volume":"15","author":"Stone","year":"2008","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.ncl.2018.07.005_bib113","doi-asserted-by":"crossref","first-page":"154631","DOI":"10.1155\/2014\/154631","article-title":"Thalamic lesions: a radiological review","volume":"2014","author":"Renard","year":"2014","journal-title":"Behav Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib114","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1136\/practneurol-2016-001571","article-title":"CJD mimics and chameleons","volume":"17","author":"Mead","year":"2017","journal-title":"Pract Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2018.07.005_bib115","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/jnnp.2004.049783","article-title":"The \"pulvinar sign\" in a case of paraneoplastic limbic encephalitis associated with non-Hodgkin's lymphoma","volume":"76","author":"Mihara","year":"2005","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.ncl.2018.07.005_bib116","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/1971400916665373","article-title":"Pulvinar sign in a case of anti-HU paraneoplastic encephalitis","volume":"29","author":"Gamache","year":"2016","journal-title":"Neuroradiol J"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib117","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4103\/0972-2327.132640","article-title":"Pulvinar sign in acute disseminated encephalomyelitis","volume":"17","author":"Dabadghao","year":"2014","journal-title":"Ann Indian Acad Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2018.07.005_bib118","first-page":"1560","article-title":"Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases","volume":"24","author":"Collie","year":"2003","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib119","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1212\/WNL.58.1.148-a","article-title":"Sporadic CJD clinically mimicking variant CJD with bilateral increased signal in the pulvinar","volume":"58","author":"Haik","year":"2002","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2018.07.005_bib120","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1001\/archneur.60.5.767","article-title":"Sporadic Creutzfeldt-Jakob disease mimicking variant Creutzfeldt-Jakob disease","volume":"60","author":"Martindale","year":"2003","journal-title":"Arch Neurol"},{"issue":"9513","key":"10.1016\/j.ncl.2018.07.005_bib121","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0140-6736(06)68344-X","article-title":"The first Japanese case of variant Creutzfeldt-Jakob disease showing periodic electroencephalogram","volume":"367","author":"Yamada","year":"2006","journal-title":"Lancet"},{"issue":"9082","key":"10.1016\/j.ncl.2018.07.005_bib122","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0140-6736(97)03148-6","article-title":"New variant Creutzfeldt-Jakob disease: psychiatric features","volume":"350","author":"Zeidler","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib123","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ana.20768","article-title":"Periodic electroencephalogram complexes in a patient with variant Creutzfeldt-Jakob disease","volume":"59","author":"Binelli","year":"2006","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2018.07.005_bib124","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/jnnp.70.6.744","article-title":"Use of 14-3-3 and other brain-specific proteins in CSF in the diagnosis of variant Creutzfeldt-Jakob disease","volume":"70","author":"Green","year":"2001","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1136\/jnnp.2005.065755","article-title":"Raised CSF phospho-tau concentrations in variant Creutzfeldt-Jakob disease: diagnostic and pathological implications","volume":"77","author":"Goodall","year":"2006","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib126","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4161\/pri.29237","article-title":"Variant CJD. 18 years of research and surveillance","volume":"8","author":"Diack","year":"2014","journal-title":"Prion"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib127","first-page":"20","article-title":"Molecular pathology, classification, and diagnosis of sporadic human prion disease variants","volume":"50","author":"Parchi","year":"2012","journal-title":"Folia Neuropathol"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00401-010-0735-5","article-title":"Molecular pathology of human prion disease","volume":"121","author":"Wadsworth","year":"2011","journal-title":"Acta Neuropathol"},{"issue":"9277","key":"10.1016\/j.ncl.2018.07.005_bib129","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0140-6736(01)05403-4","article-title":"Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay","volume":"358","author":"Wadsworth","year":"2001","journal-title":"Lancet"},{"issue":"9045","key":"10.1016\/j.ncl.2018.07.005_bib130","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0140-6736(97)24002-X","article-title":"Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy","volume":"349","author":"Hill","year":"1997","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ncl.2018.07.005_bib131","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/ana.21987","article-title":"Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease","volume":"67","author":"Heath","year":"2010","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib132","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJMc1610003","article-title":"Variant Creutzfeldt-Jakob disease in a patient with heterozygosity at PRNP Codon 129","volume":"376","author":"Mok","year":"2017","journal-title":"N\u00a0Engl J Med"},{"issue":"9707","key":"10.1016\/j.ncl.2018.07.005_bib133","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(09)61568-3","article-title":"Variant CJD in an individual heterozygous for PRNP codon 129","volume":"374","author":"Kaski","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib134","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.transci.2010.09.003","article-title":"The risk of transmitting prion disease by blood or plasma products","volume":"43","author":"Knight","year":"2010","journal-title":"Transfus Apher Sci"},{"issue":"9552","key":"10.1016\/j.ncl.2018.07.005_bib135","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0140-6736(06)69835-8","article-title":"Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report","volume":"368","author":"Wroe","year":"2006","journal-title":"Lancet"},{"issue":"9407","key":"10.1016\/j.ncl.2018.07.005_bib136","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","article-title":"Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion","volume":"363","author":"Llewelyn","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib137","first-page":"2","article-title":"Fourth case of transfusion-associated variant-CJD infection","volume":"1","author":"Health Protection Agency","year":"2007","journal-title":"Health Protection Report: weekly report"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib138","first-page":"50","article-title":"Variant Creutzfeldt-Jakob disease: an update","volume":"50","author":"Ironside","year":"2012","journal-title":"Folia Neuropathol"},{"issue":"9433","key":"10.1016\/j.ncl.2018.07.005_bib139","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(04)16811-6","article-title":"Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient","volume":"364","author":"Peden","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib140","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2516.2009.02181.x","article-title":"Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia","volume":"16","author":"Peden","year":"2010","journal-title":"Haemophilia"},{"issue":"8","key":"10.1016\/j.ncl.2018.07.005_bib141","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1111\/trf.14145","article-title":"Creutzfeldt-Jakob disease lookback study: 21 years of surveillance for transfusion transmission risk","volume":"57","author":"Crowder","year":"2017","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.ncl.2018.07.005_bib142","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1537-2995.2008.02056.x","article-title":"Lack of evidence of transfusion transmission of Creutzfeldt-Jakob disease in a US surveillance study","volume":"49","author":"Dorsey","year":"2009","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib143","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.tmrv.2007.09.003","article-title":"Transfusion transmission of human prion diseases","volume":"22","author":"Zou","year":"2008","journal-title":"Transfus Med Rev"},{"issue":"9148","key":"10.1016\/j.ncl.2018.07.005_bib144","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0140-6736(98)12075-5","article-title":"Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples","volume":"353","author":"Hill","year":"1999","journal-title":"Lancet"},{"issue":"9441","key":"10.1016\/j.ncl.2018.07.005_bib145","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/S0140-6736(04)17143-2","article-title":"Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein","volume":"364","author":"Frosh","year":"2004","journal-title":"Lancet"},{"issue":"9129","key":"10.1016\/j.ncl.2018.07.005_bib146","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(98)24035-9","article-title":"Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease","volume":"352","author":"Hilton","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ncl.2018.07.005_bib147","doi-asserted-by":"crossref","first-page":"f5675","DOI":"10.1136\/bmj.f5675","article-title":"Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey","volume":"347","author":"Gill","year":"2013","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.ncl.2018.07.005_bib148","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJMoa1404401","article-title":"Prions in the urine of patients with variant Creutzfeldt-Jakob disease","volume":"371","author":"Moda","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"9764","key":"10.1016\/j.ncl.2018.07.005_bib149","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(10)62308-2","article-title":"Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay","volume":"377","author":"Edgeworth","year":"2011","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib150","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jamaneurol.2013.6001","article-title":"Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: diagnostic accuracy and feasibility study","volume":"71","author":"Jackson","year":"2014","journal-title":"JAMA Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib151","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/path.1580","article-title":"Prevalence of lymphoreticular prion protein accumulation in UK tissue samples","volume":"203","author":"Hilton","year":"2004","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.ncl.2018.07.005_bib152","doi-asserted-by":"crossref","first-page":"f5994","DOI":"10.1136\/bmj.f5994","article-title":"How widespread is variant Creutzfeldt-Jakob disease?","volume":"347","author":"Salmon","year":"2013","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib153","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/path.2767","article-title":"Large-scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain","volume":"222","author":"de Marco","year":"2010","journal-title":"J\u00a0Pathol"},{"issue":"12","key":"10.1016\/j.ncl.2018.07.005_bib154","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJM197403212901220","article-title":"Letter: possible person-to-person transmission of Creutzfeldt-Jakob disease","volume":"290","author":"Duffy","year":"1974","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib155","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.3171\/2016.5.FOCUS15126","article-title":"Human prion diseases: surgical lessons learned from iatrogenic prion transmission","volume":"41","author":"Bonda","year":"2016","journal-title":"Neurosurg Focus"},{"issue":"10","key":"10.1016\/j.ncl.2018.07.005_bib156","doi-asserted-by":"crossref","first-page":"E1666","DOI":"10.1210\/jc.2011-1357","article-title":"Lower risk of Creutzfeldt-Jakob disease in pituitary growth hormone recipients initiating treatment after 1977","volume":"96","author":"Abrams","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"6903","key":"10.1016\/j.ncl.2018.07.005_bib157","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/bmj.307.6903.517","article-title":"Creutzfeldt-Jakob disease after pituitary gonadotrophins","volume":"307","author":"Healy","year":"1993","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib158","doi-asserted-by":"crossref","first-page":"248","DOI":"10.33321\/cdi.2001.25.41","article-title":"Transmissible spongiform encephalopathies in Australia","volume":"25","author":"Boyd","year":"2001","journal-title":"Commun Dis Intell Q Rep"},{"issue":"45","key":"10.1016\/j.ncl.2018.07.005_bib159","first-page":"1066","article-title":"Creutzfeldt-Jakob disease associated with cadaveric dura mater grafts -- Japan, January 1979-May 1996","volume":"46","author":"Centers for Disease Control and Prevention (CDC)","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib160","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1212\/01.wnl.0000266624.63387.4a","article-title":"Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease","volume":"69","author":"Noguchi-Shinohara","year":"2007","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2018.07.005_bib161","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1440-1789.2008.00987.x","article-title":"Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: clinicopathological and molecular characterization of the two distinct subtypes","volume":"29","author":"Yamada","year":"2009","journal-title":"Neuropathology"},{"key":"10.1016\/j.ncl.2018.07.005_bib162","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/2051-5960-2-32","article-title":"Distinct origins of dura mater graft-associated Creutzfeldt-Jakob disease: past and future problems","volume":"2","author":"Kobayashi","year":"2014","journal-title":"Acta Neuropathol Commun"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib163","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/jnnp.63.3.388","article-title":"Transmission of Creutzfeldt-Jakob disease via a corneal transplant","volume":"63","author":"Heckmann","year":"1997","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib164","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/00003226-200405000-00019","article-title":"Creutzfeldt-Jakob disease following corneal transplantation","volume":"23","author":"Hammersmith","year":"2004","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.ncl.2018.07.005_bib165","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/ICO.0b013e31816a628d","article-title":"Creutzfeldt-Jakob disease in recipients of corneal transplants","volume":"27","author":"Maddox","year":"2008","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.ncl.2018.07.005_bib166","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1212\/WNL.55.8.1075","article-title":"Iatrogenic Creutzfeldt-Jakob disease at the millennium","volume":"55","author":"Brown","year":"2000","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib167","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ana.410380223","article-title":"Creutzfeldt-Jakob disease after liver transplantation","volume":"38","author":"Creange","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ncl.2018.07.005_bib168","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/128_2011_159","article-title":"Chronic wasting disease","volume":"305","author":"Gilch","year":"2011","journal-title":"Top Curr Chem"},{"key":"10.1016\/j.ncl.2018.07.005_bib169","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1146\/annurev-animal-022114-111001","article-title":"Chronic wasting disease of cervids: current knowledge and future perspectives","volume":"3","author":"Haley","year":"2015","journal-title":"Annu Rev Anim Biosci"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib170","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3201\/eid1803.110685","article-title":"Occurrence, transmission, and zoonotic potential of chronic wasting disease","volume":"18","author":"Saunders","year":"2012","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.ncl.2018.07.005_bib171","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1292\/jvms.67.753","article-title":"Additional cases of chronic wasting disease in imported deer in Korea","volume":"67","author":"Kim","year":"2005","journal-title":"J\u00a0Vet Med Sci"},{"key":"10.1016\/j.ncl.2018.07.005_bib172","first-page":"267","article-title":"Chapter twelve - scrapie, CWD, and transmissible mink encephalopathy","volume":"vol. 150","author":"Mathiason","year":"2017"},{"issue":"7263","key":"10.1016\/j.ncl.2018.07.005_bib173","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature08289","article-title":"Asymptomatic deer excrete infectious prions in faeces","volume":"461","author":"Tamguney","year":"2009","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib174","doi-asserted-by":"crossref","first-page":"e4848","DOI":"10.1371\/journal.pone.0004848","article-title":"Detection of CWD prions in urine and saliva of deer by transgenic mouse bioassay","volume":"4","author":"Haley","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.ncl.2018.07.005_bib175","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00550-18","article-title":"Lack of transmission of chronic wasting disease to cynomolgus macaques","author":"Race","year":"2018","journal-title":"J\u00a0Virol"},{"issue":"8","key":"10.1016\/j.ncl.2018.07.005_bib176","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa022043","article-title":"Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease","volume":"348","author":"Zanusso","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib177","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ana.20038","article-title":"Prion deposition in olfactory biopsy of sporadic Creutzfeldt-Jakob disease","volume":"55","author":"Tabaton","year":"2004","journal-title":"Ann Neurol"},{"issue":"9154","key":"10.1016\/j.ncl.2018.07.005_bib178","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0140-6736(98)08138-0","article-title":"Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study","volume":"353","author":"Collins","year":"1999","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ncl.2018.07.005_bib179","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10654-006-9044-7","article-title":"Classification of surgical procedures for epidemiologic assessment of sporadic Creutzfeldt-Jakob disease transmission by surgery","volume":"21","author":"de Pedro-Cuesta","year":"2006","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib180","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ana.21294","article-title":"Risk factors for sporadic Creutzfeldt-Jakob disease","volume":"63","author":"Ward","year":"2008","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib181","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000163098","article-title":"Surgery and risk of sporadic Creutzfeldt-Jakob disease","volume":"31","author":"Ward","year":"2008","journal-title":"Neuroepidemiology"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib182","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ana.22094","article-title":"Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein","volume":"68","author":"Zou","year":"2010","journal-title":"Ann Neurol"},{"issue":"417","key":"10.1016\/j.ncl.2018.07.005_bib183","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam7785","article-title":"Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease","volume":"9","author":"Orru","year":"2017","journal-title":"Sci Transl Med"},{"issue":"Pt 8","key":"10.1016\/j.ncl.2018.07.005_bib184","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1099\/0022-1317-77-8-1925","article-title":"Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie","volume":"77","author":"Beekes","year":"1996","journal-title":"J\u00a0Gen Virol"},{"issue":"6","key":"10.1016\/j.ncl.2018.07.005_bib185","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nm1055","article-title":"PrPSc accumulation in myocytes from sheep incubating natural scrapie","volume":"10","author":"Andreoletti","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.ncl.2018.07.005_bib186","series-title":"WHO guidelines on tissue infectivity distribution in transmissible spongiform encephalopathies; report of the WHO consultation in Geneva 14-16 September 2005","author":"World Health Organization (WHO)","year":"2006"},{"key":"10.1016\/j.ncl.2018.07.005_bib187","unstructured":"UCSF Medical Center. Policies and procedures for patients with suspected or confirmed human prion disease (E.G., Creutzfeldt-Jakob Disease [CJD]). Hospital epidemiology and infection control 2012. Available at: http:\/\/infectioncontrol.ucsfmedicalcenter.org\/sites\/infectioncontrol.ucsfmedicalcenter.org\/files\/Sec%204.2%20Human%20Prion%20Policy.pdf. Accessed June 3, 2016."},{"key":"10.1016\/j.ncl.2018.07.005_bib188","unstructured":"World Health Organization (WHO). WHO infection control guidelines for transmissible spongiform encephalopathies: report of a WHO consultation Geneva, Switzerland, 23-26 March 1999. Presented at World Health Organization: Communicable Disease Surveillance and Control. Geneva, Switzerland, February 9\u201311, 1999."},{"key":"10.1016\/j.ncl.2018.07.005_bib189","unstructured":"UK National Health Service Advisory Committee on Dangerous Pathogens; Spongiform Encephalopathy Advisory Committee. Transmissible spongiform encephalopathy agents: safe working and the prevention of infection. Part 4 infection prevention and control of CJD and variant CJD in healthcare and community settings. 2015. London, UK. Available at: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/427854\/Infection_controlv3.0.pdf. Accessed June 21, 2018."},{"key":"10.1016\/j.ncl.2018.07.005_bib190","unstructured":"Australian Government Department of Public Health. Infection control guidelines: Creutzfeldt-Jakob disease. 2013; CJD and prion infection control guidelines. Available at: http:\/\/www.health.gov.au\/internet\/main\/publishing.nsf\/content\/icg-guidelines-index.htm. Accessed July 18, 2018."},{"issue":"8","key":"10.1016\/j.ncl.2018.07.005_bib191","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1111\/trf.14239","article-title":"Creutzfeldt-Jakob disease and blood transfusion: safe or not safe?","volume":"57","author":"Cervenakova","year":"2017","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib192","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/vox.12371","article-title":"Creutzfeldt-Jakob disease and blood transfusion: updated results of the UK transfusion medicine epidemiology review study","volume":"110","author":"Urwin","year":"2016","journal-title":"Vox Sang"},{"issue":"Pt 5","key":"10.1016\/j.ncl.2018.07.005_bib193","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1093\/brain\/awm063","article-title":"Creutzfeldt-Jakob disease in Germany: a prospective 12-year surveillance","volume":"130","author":"Heinemann","year":"2007","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib194","first-page":"735","article-title":"Brain biopsy in patients with suspected Creutzfeldt-Jakob disease","volume":"109","author":"Heinemann","year":"2008","journal-title":"J\u00a0Neurosurg"},{"issue":"3","key":"10.1016\/j.ncl.2018.07.005_bib195","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ana.22454","article-title":"Treatable neurological disorders misdiagnosed as Creutzfeldt-Jakob disease","volume":"70","author":"Chitravas","year":"2011","journal-title":"Ann Neurol"},{"issue":"6088","key":"10.1016\/j.ncl.2018.07.005_bib196","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1126\/science.1222951","article-title":"Cell biology. A unifying role for prions in neurodegenerative diseases","volume":"336","author":"Prusiner","year":"2012","journal-title":"Science"},{"issue":"7465","key":"10.1016\/j.ncl.2018.07.005_bib197","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nature12481","article-title":"Self-propagation of pathogenic protein aggregates in neurodegenerative diseases","volume":"501","author":"Jucker","year":"2013","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.ncl.2018.07.005_bib198","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","article-title":"Prions","volume":"95","author":"Prusiner","year":"1998","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib199","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ncb1830","article-title":"Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates","volume":"11","author":"Ren","year":"2009","journal-title":"Nat Cell Biol"},{"issue":"15","key":"10.1016\/j.ncl.2018.07.005_bib200","doi-asserted-by":"crossref","first-page":"5176","DOI":"10.1523\/JNEUROSCI.5351-09.2010","article-title":"Metabotropic glutamate receptor 1 mediates the electrophysiological and toxic actions of the cycad derivative beta-N-Methylamino-L-alanine on substantia nigra pars compacta DAergic neurons","volume":"30","author":"Cucchiaroni","year":"2010","journal-title":"J\u00a0Neurosci"},{"issue":"9","key":"10.1016\/j.ncl.2018.07.005_bib201","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1073\/pnas.1017275108","article-title":"Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells","volume":"108","author":"Munch","year":"2011","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"12","key":"10.1016\/j.ncl.2018.07.005_bib202","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.bbadis.2011.09.005","article-title":"Molecular properties of TAR DNA binding protein-43 fragments are dependent upon its cleavage site","volume":"1812","author":"Furukawa","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ncl.2018.07.005_bib203","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev-genet-110711-155524","article-title":"Biology and genetics of prions causing neurodegeneration","volume":"47","author":"Prusiner","year":"2013","journal-title":"Annu Rev Genet"},{"issue":"10","key":"10.1016\/j.ncl.2018.07.005_bib204","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.1523\/JNEUROSCI.20-10-03606.2000","article-title":"Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice","volume":"20","author":"Kane","year":"2000","journal-title":"J\u00a0Neurosci"},{"issue":"6006","key":"10.1016\/j.ncl.2018.07.005_bib205","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1126\/science.1194516","article-title":"Peripherally applied Abeta-containing inoculates induce cerebral beta-amyloidosis","volume":"330","author":"Eisele","year":"2010","journal-title":"Science"},{"issue":"31","key":"10.1016\/j.ncl.2018.07.005_bib206","doi-asserted-by":"crossref","first-page":"12926","DOI":"10.1073\/pnas.0903200106","article-title":"Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation","volume":"106","author":"Eisele","year":"2009","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ncl.2018.07.005_bib207","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1126\/science.1131864","article-title":"Exogenous induction of cerebral beta-amyloidogenesis is governed by agent and host","volume":"313","author":"Meyer-Luehmann","year":"2006","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib208","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.22615","article-title":"Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders","volume":"70","author":"Jucker","year":"2011","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib209","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00401-011-0912-1","article-title":"The presence of Abeta seeds, and not age per se, is critical to the initiation of Abeta deposition in the brain","volume":"123","author":"Hamaguchi","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib210","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40478-017-0503-z","article-title":"Iatrogenic Creutzfeldt-Jakob disease with Amyloid-beta pathology: an international study","volume":"6","author":"Cali","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"9","key":"10.1016\/j.ncl.2018.07.005_bib211","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/NEN.0000000000000228","article-title":"Prion disease induces Alzheimer disease-like neuropathologic changes","volume":"74","author":"Tousseyn","year":"2015","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"7568","key":"10.1016\/j.ncl.2018.07.005_bib212","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature15369","article-title":"Evidence for human transmission of amyloid-beta pathology and cerebral amyloid angiopathy","volume":"525","author":"Jaunmuktane","year":"2015","journal-title":"Nature"},{"issue":"7568","key":"10.1016\/j.ncl.2018.07.005_bib213","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/525193a","article-title":"Neurodegeneration: amyloid-beta pathology induced in humans","volume":"525","author":"Jucker","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib214","doi-asserted-by":"crossref","first-page":"74","DOI":"10.4161\/pri.3.2.8754","article-title":"The expanding realm of prion phenomena in neurodegenerative disease","volume":"3","author":"Frost","year":"2009","journal-title":"Prion"},{"key":"10.1016\/j.ncl.2018.07.005_bib215","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/srep00700","article-title":"Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau","volume":"2","author":"Lasagna-Reeves","year":"2012","journal-title":"Sci Rep"},{"issue":"23","key":"10.1016\/j.ncl.2018.07.005_bib216","doi-asserted-by":"crossref","first-page":"9535","DOI":"10.1073\/pnas.1301175110","article-title":"Brain homogenates from human tauopathies induce tau inclusions in mouse brain","volume":"110","author":"Clavaguera","year":"2013","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.ncl.2018.07.005_bib217","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.clineuro.2016.09.006","article-title":"Prion diseases: new considerations","volume":"150","author":"Annus","year":"2016","journal-title":"Clin Neurol Neurosurg"},{"issue":"7335","key":"10.1016\/j.ncl.2018.07.005_bib218","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature09768","article-title":"Prion propagation and toxicity in\u00a0vivo occur in two distinct mechanistic phases","volume":"470","author":"Sandberg","year":"2011","journal-title":"Nature"},{"issue":"695","key":"10.1016\/j.ncl.2018.07.005_bib219","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1749-6632.1993.tb23043.x","article-title":"The C-terminus of the beta-protein is critical in amyloidogenesis","volume":"695","author":"Jarrett","year":"1993","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.ncl.2018.07.005_bib220","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","article-title":"Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson's disease","volume":"14","author":"Kordower","year":"2008","journal-title":"Nat Med"},{"issue":"16","key":"10.1016\/j.ncl.2018.07.005_bib221","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/mds.22369","article-title":"Transplanted dopaminergic neurons develop PD pathologic changes: a second case report","volume":"23","author":"Kordower","year":"2008","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.ncl.2018.07.005_bib222","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","article-title":"Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation","volume":"14","author":"Li","year":"2008","journal-title":"Nat Med"},{"issue":"48","key":"10.1016\/j.ncl.2018.07.005_bib223","doi-asserted-by":"crossref","first-page":"19555","DOI":"10.1073\/pnas.1318268110","article-title":"Transmission of multiple system atrophy prions to transgenic mice","volume":"110","author":"Watts","year":"2013","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"38","key":"10.1016\/j.ncl.2018.07.005_bib224","doi-asserted-by":"crossref","first-page":"E5308","DOI":"10.1073\/pnas.1514475112","article-title":"Evidence for alpha-synuclein prions causing multiple system atrophy in humans with parkinsonism","volume":"112","author":"Prusiner","year":"2015","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib225","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-4422(17)30037-6","article-title":"The prion model for progression and diversity of neurodegenerative diseases","volume":"16","author":"Stopschinski","year":"2017","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2018.07.005_bib226","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1528-1157.2003.07802.x","article-title":"Brain diffusion after single seizures","volume":"44","author":"Hufnagel","year":"2003","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib227","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.seizure.2008.07.004","article-title":"Frequency and patterns of MRI abnormalities due to status epilepticus","volume":"18","author":"Milligan","year":"2009","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.ncl.2018.07.005_bib228","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1148\/radiology.212.2.r99au36333","article-title":"Acute cerebral infarction: quantification of spin-density and T2 shine-through phenomena on diffusion-weighted MR images","volume":"212","author":"Burdette","year":"1999","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib229","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1445-5994.1990.tb01322.x","article-title":"Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin","volume":"20","author":"Cochius","year":"1990","journal-title":"Aust N Z J Med"},{"issue":"11","key":"10.1016\/j.ncl.2018.07.005_bib230","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1136\/jnnp.55.11.1094","article-title":"Creutzfeldt-Jakob disease in a recipient of human pituitary-derived gonadotrophin: a second case","volume":"55","author":"Cochius","year":"1992","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.ncl.2018.07.005_bib231","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0764-4469(97)82774-6","article-title":"Putative neurosurgical transmission of Creutzfeldt-Jakob disease with analysis of donor and recipient: agent strains","volume":"320","author":"el Hachimi","year":"1997","journal-title":"C\u00a0R Acad Sci III"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861918312489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861918312489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:17:50Z","timestamp":1760005070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861918312489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":231,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0733861918312489"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2018.07.005","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prion Diseases","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2018.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}